Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.22 USD
-0.02 (-1.61%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $1.28 +0.06 (4.92%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 42% (105 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.78 | 1.52 | 9.99 |
Current Quarter Estimate | -0.19 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.42 | -0.59 | 54.84 |
Next Quarter Estimate | -0.18 | -2.00 | 63.00 |
Next Year Estimate | -0.68 | 6.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 50.32 | 13.50 | 15.67 |
Next Year | 11.69 | 16.70 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 24.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 0.62 | 1.58 |
Price/Cash Flow (MRFY) | NA | 8.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -248.28% | 6.02% |
Return on Equity (TTM) | -61.03% | 7.75% |
Debt to Equity (MRQ) | NA | 2.23 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.